S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Fisher & Paykel Healthcare Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume575,466 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield1.21%

Receive FPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.


See More Headlines

Industry, Sector and Symbol

Medical Devices
Year Founded

Sales & Book Value

Annual Sales
$1.97 billion
Book Value
A$2.64 per share





Next Earnings Date
Not Optionable


Overall MarketRank

1.47 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Fisher & Paykel Healthcare (ASX:FPH) Frequently Asked Questions

What stocks does MarketBeat like better than Fisher & Paykel Healthcare?

Wall Street analysts have given Fisher & Paykel Healthcare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fisher & Paykel Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Fisher & Paykel Healthcare pay dividends? What is the dividend yield for Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare announced a Final dividend on Friday, May 28th. Shareholders of record on Tuesday, July 6th will be given a dividend of 0.2065 per share on Tuesday, July 6th. This represents a yield of 0.75%. The ex-dividend date of this dividend is Wednesday, June 23rd. This is an increase from Fisher & Paykel Healthcare's previous Final dividend of A$0.15.
View Fisher & Paykel Healthcare's dividend history

Is Fisher & Paykel Healthcare a good dividend stock?

Fisher & Paykel Healthcare pays an annual dividend of A$0.36 per share and currently has a dividend yield of 1.21%. The dividend payout ratio of Fisher & Paykel Healthcare is 41.62%. This payout ratio is at a healthy, sustainable level, below 75%.
View Fisher & Paykel Healthcare's dividend history.

Who are Fisher & Paykel Healthcare's key executives?

Fisher & Paykel Healthcare's management team includes the following people:
  • Mr. Lewis G. Gradon, MD, CEO & Exec. Director (Age 60, Pay $2.08M)
  • Ms. Lyndal York, Chief Financial Officer
  • Dr. Andrew Somervell, VP of Products & Technology
  • Hayden Brown, Investor Relations Mang.
  • Karen Knott, Gen. Mang. of Corp. Communications
  • Mr. Paul N. Shearer, Sr. VP of Sales & Marketing
  • Ms. Nicola Talbot, VP of HR
  • Mr. Marcus Driller, VP of Corp. & Company Sec.

What other stocks do shareholders of Fisher & Paykel Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fisher & Paykel Healthcare investors own include ServiceNow (NOW), Allena Pharmaceuticals (ALNA), Broadcom (AVGO), Okta (OKTA), Taiwan Semiconductor Manufacturing (TSM), (ALT), Ampliphi Biosciences (APHB), Avid Technology (AVID), American Express (AXP) and Alteryx (AYX).

What is Fisher & Paykel Healthcare's stock symbol?

Fisher & Paykel Healthcare trades on the ASX under the ticker symbol "FPH."

How much money does Fisher & Paykel Healthcare make?

Fisher & Paykel Healthcare has a market capitalization of $0.00 and generates $1.97 billion in revenue each year.

How many employees does Fisher & Paykel Healthcare have?

Fisher & Paykel Healthcare employs 160 workers across the globe.

What is Fisher & Paykel Healthcare's official website?

The official website for Fisher & Paykel Healthcare is www.fphcare.com.

Where are Fisher & Paykel Healthcare's headquarters?

Fisher & Paykel Healthcare is headquartered at 15 Maurice Paykel Place, East Tamaki, AUCKLAND, 1061, New Zealand.

How can I contact Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare's mailing address is 15 Maurice Paykel Place, East Tamaki, AUCKLAND, 1061, New Zealand. The company can be reached via phone at +64-9-5740100.

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.